Bull
$28.42
Scenario price
$59.130
-1.721 (-2.91%)At close
BrightSpring Health Services, Inc. provides complementary home and community-based pharmacy and provides health solutions for complex populations in need of specialized and/or chronic care. Through the Company's service lines, including pharmacy, home health care and rehab care, it provides comprehensive and more integrated care and clinical solutions in all 50 states to customers, clients and patients. Its services are organized and managed through two reportable segments: Pharmacy Solutions and Provider Services. The Pharmacy Solutions segment operates long-term institutional pharmacies, hospice pharmacies, specialty oncology pharmacies, and home infusion centers. It provides infused, injectable, and oral medication services in the home and clinic. The Provider Services segment provides a variety of services to help manage the whole-person health of its patients in their homes and communities through services such as home health care and hospice care and long-term specialty care.
Brightspring Health Services Inc is a good buy right now due to its strong revenue growth and positive analyst sentiment. The current price of $59.13 is below the average analyst price target of $78.75, indicating significant upside potential. Additionally, the company has shown a remarkable year-to-date change of +53.98% and a one-year change of +147.61%, reflecting strong market performance. However, the RSI is currently at 44.194, suggesting that the stock is not overbought, which could provide a favorable entry point for long-term investors. The main risk is the recent volatility, as evidenced by a 17.5% drop following strong earnings, indicating potential market sensitivity to performance metrics.
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

BrightSpring Health Services Stock Soars 47.6%

BrightSpring Health (BTSG) Q2 2026 Earnings Call Transcript

BrightSpring Health Services Shares Drop 17.5% Despite Strong Q2 Results

BrightSpring Health Services Q2 Results Beat Expectations but Stock Drops 18%

BrightSpring Health Services Reports Strong Q2 2026 Earnings
BrightSpring Health Services, Inc. provides complementary home and community-based pharmacy and provides health solutions for complex populations in need of specialized and/or chronic care. Through the Company's service lines, including pharmacy, home health care and rehab care, it provides comprehensive and more integrated care and clinical solutions in all 50 states to customers, clients and patients. Its services are organized and managed through two reportable segments: Pharmacy Solutions and Provider Services. The Pharmacy Solutions segment operates long-term institutional pharmacies, hospice pharmacies, specialty oncology pharmacies, and home infusion centers. It provides infused, injectable, and oral medication services in the home and clinic. The Provider Services segment provides a variety of services to help manage the whole-person health of its patients in their homes and communities through services such as home health care and hospice care and long-term specialty care. It operates in the Healthcare sector (HOME HEALTH CARE SERVICES industry).
Brightspring Health Services Inc is a good buy right now due to its strong revenue growth and positive analyst sentiment. The current price of $59.13 is below the average analyst price target of $78.75, indicating significant upside potential. Additionally, the company has shown a remarkable year-to-date change of +53.98% and a one-year change of +147.61%, reflecting strong market performance. However, the RSI is currently at 44.194, suggesting that the stock is not overbought, which could provide a favorable entry point for long-term investors. The main risk is the recent volatility, as evidenced by a 17.5% drop following strong earnings, indicating potential market sensitivity to performance metrics.
本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。